West Pharmaceutical Services (NYSE:WST) Trading Down 6.9%

West Pharmaceutical Services, Inc. (NYSE:WST)’s stock price fell 6.9% during trading on Tuesday . The company traded as low as $312.00 and last traded at $312.78. 426,336 shares were traded during trading, a decline of 18% from the average session volume of 522,832 shares. The stock had previously closed at $336.08.

West Pharmaceutical Services Trading Down 4.2 %

The company has a quick ratio of 1.95, a current ratio of 2.61 and a debt-to-equity ratio of 0.03. The business’s fifty day moving average is $352.65 and its 200 day moving average is $361.87. The firm has a market capitalization of $23.46 billion, a price-to-earnings ratio of 42.49, a price-to-earnings-growth ratio of 5.88 and a beta of 1.01.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings results on Thursday, April 25th. The medical instruments supplier reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.29 by $0.27. West Pharmaceutical Services had a net margin of 19.42% and a return on equity of 20.57%. The firm had revenue of $695.40 million for the quarter, compared to analyst estimates of $670.62 million. During the same period in the previous year, the business earned $1.98 EPS. The company’s revenue was down 3.0% compared to the same quarter last year. Equities analysts predict that West Pharmaceutical Services, Inc. will post 7.76 earnings per share for the current year.

West Pharmaceutical Services Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, August 7th. Shareholders of record on Wednesday, July 31st will be paid a $0.20 dividend. The ex-dividend date is Wednesday, July 31st. This represents a $0.80 annualized dividend and a yield of 0.25%. West Pharmaceutical Services’s payout ratio is currently 10.55%.

Insider Buying and Selling at West Pharmaceutical Services

In other news, CEO Eric Mark Green sold 66,000 shares of West Pharmaceutical Services stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $366.65, for a total value of $24,198,900.00. Following the completion of the transaction, the chief executive officer now owns 152,908 shares of the company’s stock, valued at approximately $56,063,718.20. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, CEO Eric Mark Green sold 66,000 shares of West Pharmaceutical Services stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $366.65, for a total value of $24,198,900.00. Following the completion of the transaction, the chief executive officer now owns 152,908 shares of the company’s stock, valued at approximately $56,063,718.20. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Silji Abraham sold 1,800 shares of West Pharmaceutical Services stock in a transaction dated Wednesday, June 12th. The shares were sold at an average price of $330.78, for a total transaction of $595,404.00. Following the completion of the transaction, the senior vice president now directly owns 2,860 shares of the company’s stock, valued at approximately $946,030.80. The disclosure for this sale can be found here. Company insiders own 0.53% of the company’s stock.

Institutional Trading of West Pharmaceutical Services

Hedge funds and other institutional investors have recently modified their holdings of the stock. Fidelis Capital Partners LLC acquired a new position in West Pharmaceutical Services during the 1st quarter worth approximately $27,000. Quarry LP increased its position in West Pharmaceutical Services by 155.3% during the 4th quarter. Quarry LP now owns 97 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 59 shares in the last quarter. Planned Solutions Inc. acquired a new position in West Pharmaceutical Services during the 4th quarter worth approximately $39,000. Hazlett Burt & Watson Inc. acquired a new position in West Pharmaceutical Services during the 1st quarter worth approximately $40,000. Finally, Northwest Investment Counselors LLC acquired a new position in West Pharmaceutical Services during the 1st quarter worth approximately $40,000. Institutional investors own 93.90% of the company’s stock.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.